🇺🇸 Salmeterol Fluticasone in United States

269 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 46 reports (17.1%)
  2. Drug Interaction — 31 reports (11.52%)
  3. Asthma — 28 reports (10.41%)
  4. Drug Ineffective — 27 reports (10.04%)
  5. Fatigue — 24 reports (8.92%)
  6. Nausea — 24 reports (8.92%)
  7. Weight Decreased — 24 reports (8.92%)
  8. Pneumonia — 23 reports (8.55%)
  9. Diarrhoea — 21 reports (7.81%)
  10. Pyrexia — 21 reports (7.81%)

Source database →

Other Respiratory/Pulmonology approved in United States

Frequently asked questions

Is Salmeterol Fluticasone approved in United States?

Salmeterol Fluticasone does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Salmeterol Fluticasone in United States?

Università degli Studi di Brescia is the originator. The local marketing authorisation holder may differ — check the official source linked above.